Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Virus entry into a susceptible host cell is the first step in the formation of all viral diseases. Controlling viral infections by disrupting viral entry is advantageous for antibody-mediated neutralization by the host’s immune system and as a preventive and therapeutic antiviral strategy. Recently, several plant-derived carbohydrate-binding proteins (lectins) have emerged as a new class of antiviral biologics by taking advantage of a unique glycosylation pattern only found on the surface of viruses. In particular, a red algae-derived griffithsin (GRFT) protein has demonstrated superior in vitro and in vivo antiviral activity with minimum host toxicity against a variety of clinically relevant, enveloped viruses. This review examines the structural characteristics of GRFT, focusing on its carbohydrate-binding capability. Its in vitro antiviral profiles against human immunodeficiency virus (HIV) are also discussed followed by a description of the results from a combination study using anti-HIV drugs. The results of several studies regarding its novel antiviral mechanism of action are provided in conjunction with an explanation of viral resistance profiles to GRFT. In addition, its in vitro and in vivo host toxicity profiles are summarized with its pharmacokinetic behavior using in vivo efficacy study results. Also, a large-scale production and formulation strategy, as well as a drug delivery strategy, for GRFT as a new class of broad-spectrum microbicides is discussed. Finally, results from two ongoing clinical studies examining GRFT’s effects on viruses are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The amino acid sequence of griffithsin (GRFT). Corresponding secondary β-sheet structures are marked with yellow arrows based on the crystal structure of a GRFT dimer with mannose at a resolution of 1.78 Å [19]. Tyrosine and aspartate residues in three carbohydrate-binding domains, which are essential for mannose-binding, are noted with blue and orange arrows, respectively. Wild-type GRFT has a non-standard amino acid at position 31, but it is replaced by alanine (colored in red) in recombinant GRFT. The sequence display was generated by the RCSB protein data bank website (www.rcsb.org).](https://figures.cochat.ai/paper-figures/1fd42505c6ef428985401d5005e46d4b/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-1.jpg)
![Figure 2 The crystal structure of a GRFT dimer with six mannoses at a resolution of 1.78 Å [19]. Each GRFT monomer is presented in either red or blue. Six bound mannose molecules are shown with ball and stick models. This image was created with PDB ID and associated publication, NGL Viewer (AS Rose et al. (2018) NGL viewer: web-based molecular graphics for large complexes. Bioinformatics doi:10.1093/bioinformatics/bty419), and RCSB PDB.](https://figures.cochat.ai/paper-figures/bc6833ca02e5443ca2b5789603c52e60/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some cyanobacteria and microalgae contain specific compounds which have been shown to have potent antiviral properties.”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This includes red algae lectins such as griffithsin from marine Griffithsia sp. (Lee, 2019) and cyanobacterial lectins such as Cyanovirin-N from freshwater Nostoc ellipsosporum (Lotfi et al., 2018).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Global epidemiology of HIV infection in men who have sex with men
Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60821-6 · Cited by 1,559
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
O'Keefe, B. R., Vojdani, F., Buffa, V., Shattock, R. J., Montefiori, D. C., Bakke, J., Mirsalis, J., d'Andrea, A.-L., Hume, S. D., Bratcher, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901506106 · Cited by 262
A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication
Swanson, M. D., Winter, H. C., Goldstein, I. J., & Markovitz, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034926 · Cited by 214
Toxicity of antiretroviral therapy and implications for drug development
Carr, A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1151 · Cited by 191
Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin
O'Keefe, B. R., Smee, D. F., Turpin, J. A., Saucedo, C. J., Gustafson, K. R., Mori, T., Blakeslee, D., Buckheit, R., & Boyd, M. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2518-2525.2003 · Cited by 188
Ziółkowska, N. E., O'Keefe, B. R., Mori, T., Zhu, C., Giomarelli, B., Vojdani, F., Palmer, K. E., McMahon, J. B., & Wlodawer, A. (2006) · Structure · doi:10.1016/j.str.2006.05.017 · Cited by 172
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
Lusvarghi, S., & Bewley, C. A. (2016) · Viruses · doi:10.3390/v8100296 · Cited by 164
Cited by
Items 101–143 of 143
Chakraborty, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-92174-3_20 · Cited by 2
Role of Marine Natural Products in Combating SARS-CoV-2 and COVID-19
Amayindi, M., Onimisi, J. Y., Yakubu, J., & Kaduna, R. D. (2025) · medtigo Journal of Medicine · doi:10.63096/medtigo3061222 · Cited by 2
Perera, C. O., & Alzahrani, M. A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92174-3_19 · Cited by 2
Besednova, N. N., Zaporozhets, T. S., Andryukov, B. G., Ermakova, S. P., Kuznetsova, T. A., Kryzhanovsky, S. P., & MIu, S. (2022) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2022-67-3-4-53-69 · Cited by 2
Herpes Simplex Viruses Type 1 and Type 2
Reyes, A., Farías, M. A., Corrales, N., Tognarelli, E. I., & González, P. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00062-8 · Cited by 3
Nazar, F. A. (2021) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/trz5s · Cited by 2
Expression and antiviral application of exogenous lectin (griffithsin) in sweetpotatoes
Liu, S., Yu, Y., Guo, K., Zhang, Q., Jia, Z., Alfredo, M. R., Ma, P., Xie, H., & Bian, X. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1421244 · Cited by 1
Ramachandran, M., Parthiban, E., Ramanibai, R., & Jayakumar, M. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2477812 · Cited by 1
Oninku, B., & Ozbay, G. (2026) · Journal of Marine Science and Engineering · doi:10.3390/jmse14131155 · Cited by 2
Griffithsin; A Potential Therapeutic Agent for SARS-CoV-2
Siddiqui, S., & Ahmed, A. (2022) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2022.05.1006 · Cited by 1
Nanotechnology: New frontiers in anti-HIV therapy
Jampílek, J., & Kráľová, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99596-2.00011-x · Cited by 1
Algal Bioactive Compounds against Sexually Transmitted Diseases
Sen, S., Satpati, G. G., & Basu, P. (2022) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3009 · Cited by 1
Repurposed Drugs Against SARS-CoV-2 Replication in COVID-19
Verma, K., Mishra, Y., Singh, S., Kapoor, N., & Yadav, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123197123010006 · Cited by 1
Genome-wide analysis of lectins in cyanobacteria: from evolutionary mode to motif patterns
Xu, T., Cui, Y., Qin, S., & Wang, Y. (2023) · BMC Genomics · doi:10.1186/s12864-023-09790-8 · Cited by 1
Potencial uso terapéutico de las plantas medicinales y sus derivados frente a los coronavirus
Fuel, M., & Cangui-Panchi, S. P. (2020) · Revista Bases de la Ciencia · doi:10.33936/rev_bas_de_la_ciencia.v5i3.2507 · Cited by 1
Q-Griffithsin interactions and utility for the prevention and treatment of Mucosal infections.
Nabeta, H. W. (2021) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3766 · Cited by 1
Heindel, D. W., Acosta, D. F., Goff, M., Jan, M., Wang, X., Petrova, M., Chan, K.-W., Kong, X., Chen, B. K., Mahal, L. K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2596269/v1 · Cited by 1
Heindel, D. W., Acosta, D. F., Goff, M., Jan, M., Wang, X., Petrova, M., Chan, K.-W., Kong, X., Chen, B. K., Mahal, L. K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-2596269/v2 · Cited by 1
Marine Natural Products: A Promising Frontier in Drug Discovery
Kazi, T. A., Chakravarti, R., Arya, M., Roy, D., Khan, A. N., Kundu, A., Gupta, R. K., Ghosh, A., & Bhattacharya, B. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-5878-8.ch002 · Cited by 1
(2021) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2021/10.11.5697
Sanyal, D., Desai, D., Chandrashekharaiah, P. S., Dwivedi, V., & Dasgupta, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90958-7.00027-3
Overview of SARS-CoV-2 and Possible Targets for the Management of COVID-19 Infections
Muthuraman, A., Ramesh, M., Subramanian, A., Dhamodharan, J., & Giap, L. K. (2022) · Coronaviruses · doi:10.2174/2666796703666220623090158
Madasu, P. K., & Chandran, T. (2022) · Preprints.org · doi:10.20944/preprints202208.0515.v1
Antimicrobial protein and peptides from marine macroalgae
Caprani, M., O’Keeffe, J., Slattery, O., & Healy, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98819-3.00005-5
Patent Highlights February–March 2023
Mucke, H. A. (2023) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2023-0023
SARS-CoV-2 spike protein in infectivity
Altaie, A. M., Hamdy, R., Husseiny, M. I., & Soliman, S. S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19170-1.00015-2
Mamun, M. R., Kabir, S. R., Hasan, I., Asaduzzaman, A. K. M., & Alam, M. T. (2025) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750825600116
Additional file 1 of A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022
Tao, X., Wang, G., Wei, W., Su, J., Chen, X., Shi, M., Liao, Y., Qin, T., Wu, Y., Lu, B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669445
Xu, T., Cui, Y., Qin, S., & Wang, Y.-C. (2024) · Figshare · doi:10.6084/m9.figshare.26641207
Additional file 2 of A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022
Tao, X., Wang, G., Wei, W., Su, J., Chen, X., Shi, M., Liao, Y., Qin, T., Wu, Y., Lu, B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669448
Xu, T., Cui, Y., Qin, S., & Wang, Y.-C. (2024) · Figshare · doi:10.6084/m9.figshare.26641204
Xu, T., Cui, Y., Qin, S., & Wang, Y.-C. (2024) · Figshare · doi:10.6084/m9.figshare.26641201
Additional file 3 of A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022
Tao, X., Wang, G., Wei, W., Su, J., Chen, X., Shi, M., Liao, Y., Qin, T., Wu, Y., Lu, B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669451
Bains, A. (2023) · eScholarship (California Digital Library)
Soni, S., D’souza, K., Kaur, G., Buttar, H. S., & Kanase, V. (2026) · Advances in biochemistry in health and disease · doi:10.1007/978-3-032-14441-6_21
55122 Modern techniques leading to bioactive compound discoveries in plants: case studies
Chaitanya, M. V. N. L., Manjusha, K. G., Pal, R. S., Lakshmi, K. A., Singh, S., & Sindhu, R. K. (2026) · De Gruyter eBooks · doi:10.1515/9783111628240-027
Saito, T., Furuyama, W., Muthusinghe, D. S., Munyeku-Bazitama, Y., Hattori, T., Okabe, M., Yokoyama, T., Tanaka, Y., Sakai, R., Sakurai, Y., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00372-26
Addressing Challenges in Harvesting Algal Biomass for Pharmaceutical Applications
Goel, N., Naaz, H., Gola, D., Saxena, M., & Choudhary, P. (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-8431-4_12
Shandul, A., Rathod, A. K., Dixit, S., Patel, K. N., & Manna, M. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp01134a
Beyond one drug–one target: AI-guided discovery of multi-target antiviral therapeutics
Gupta, V., Sharma, S., Abbot, V., Bhatia, R., Choudhary, N., & Kumar, D. (2026) · Frontiers in Virology · doi:10.3389/fviro.2026.1853552
Landscape of small molecules derived from marine sources and their clinical progression
Vanangamudi, M., Jain, A. V., Singh, T. G., Goel, K. K., & Bansal, N. (2026) · Xenobiotica · doi:10.1080/00498254.2026.2751092
Marine algal bioactive potential in medicinal field
Li, Q., & Jin, Z. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51070-0.00007-0
BindingDB (2023) · UC San Diego · doi:10.7270/q27p93c8
Metadata
- Authors
- Lee, C.
- Affiliations
- College of Pharmacy, Dongguk University, Goyang 10326, Korea
- ORCID
- Lee, Choongho
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-10-06
- Volume
- 17
- Issue
- 10
- Pages
- 567
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6835697
- OpenAlex
- W2979023383
- Cited by
- 138
- References
- 64
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 19
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF) (NRF-2019R1F1A1058628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- griffithsin, antiviral lectin, red algae, carbohydrate-binding proteins, viral entry inhibition, HIV, microbicides, host toxicity, pharmacokinetics, drug resistance, combination antiviral therapy, drug delivery, clinical trials
- MeSH terms
- Rhodophyta, Amino Acid Sequence, Animals, Antiviral Agents, Humans, HIV-1, HIV Infections, Plant Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.